Literature DB >> 2646246

Frey's syndrome: treatment with topical glycopyrrolate.

J S May1, W F McGuirt.   

Abstract

Gustatory sweating and flushing of the facial skin, or Frey's syndrome, is fairly common after parotidectomy. The most likely mechanism is aberrant reinnervation of the sweat glands of the face by the severed parotid parasympathetic nerve fibers. A survey of 61 patients having undergone parotidectomy yielded 29 (47.5%) with gustatory sweating. Twenty-three percent (14 patients) considered the symptoms severe. In a double-blind study, five of those 14 patients were alternately treated with topically applied placebo and with glycopyrrolate (an anticholinergic agent) as 0.5% lotion, 2% lotion, and 2% cream. All five patients showed some improvement with the test preparations, but had longer lasting and more effective lessening of symptoms with the 2% glycopyrrolate preparations. There were no adverse side effects. We therefore believe that the topical application of a 2% glycopyrrolate preparation is a safe and effective treatment for severe gustatory sweating following parotidectomy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646246     DOI: 10.1002/hed.2880110115

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  The mydriatic effect of topical glycopyrrolate.

Authors:  D Varssano; S Rothman; K Haas; M Lazar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

2.  Frey syndrome in a patient with facial melanoma: auriculotemporal syndrome presenting with gustatory sweating following wide local excision, sentinel node biopsy, and superficial parotidectomy.

Authors:  Richard R Jahan-Tigh; Philip R Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2012-07

3.  Effect of human acellular dermal matrix (Megaderm™) on infra-auricular depressed deformities, Frey's syndrome, and first bite syndrome following parotidectomy: a multi-center prospective study.

Authors:  Joo Hyun Kim; Da Hee Kim; Jae-Yol Lim; Ho-Ryun Won; Yoo Seob Shin; Chul-Ho Kim; Myung Jin Ban; Jae Hong Park; Hyung Kwon Byeon; Hyun Jun Hong; Eun Chang Choi; Woon Yoo Koh
Journal:  Gland Surg       Date:  2021-02

4.  Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles.

Authors:  Shang Xie; Kan Wang; Tao Xu; Xue-Sheng Guo; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Cancer Med       Date:  2015-08-26       Impact factor: 4.452

5.  Iontophoretic and microneedle mediated transdermal delivery of glycopyrrolate.

Authors:  Meera Gujjar; Ajay K Banga
Journal:  Pharmaceutics       Date:  2014-12-22       Impact factor: 6.321

6.  A Novel Method for Studying the Pharmacokinetics of [(14) C]Umeclidinium After Application to the Axilla or Palm of Healthy Male Subjects.

Authors:  T Pene Dumitrescu; L L Santos; S C Hughes; A I Pereira; G C Young; E Hussey; P Charlton; S Baptiste-Brown; J S Stuart; V Vincent; S P van Marle; V D Schmith
Journal:  Clin Transl Sci       Date:  2016-06-15       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.